Use of a clinician-facing dashboard combined with a best practice alert helped increase rates of HLA-B*58:01 genetic testing among patients prescribed allopurinol.

Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind®, the leader in comprehensive genetics and digital mental health services, has pioneered a new level of specificity and accuracy for cheek swab-based ...

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the forecast period. Market growth is driven by the rising demand for organ and ...

CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...

HLA testing is being used in the field of pharmacogenomics to find the possible drug hypersensitivity reaction. 01 has been identified as a possible marker for abacavir-induced hypersensitivity, and ...

Deal includes assets, infrastructure, and sales team related to the Olerup SSP line. LinkMed is taking over distribution rights to Qiagen’s Olerup SSP® product line, which consists of genomic HLA ...

ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a bone marrow transplant (BMT) ...